No Data
UK Court Sides With Pfizer, BioNTech in MRNA Patent Case Against CureVac
Express News | Pfizer (PFE.N) and the German biotechnology company BioNTech have won a lawsuit in the United Kingdom court, successfully invalidating CureVac's patent on mRNA technology in the COVID-19 vaccine.
Express News | Pfizer, BioNTech Win Bid in UK Court to Invalidate CureVac's Patents Over Mrna Technology in Covid-19 Vaccines
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
CureVac N.V.'s (NASDAQ:CVAC) Top Owners Are Individual Investors With 35% Stake, While 31% Is Held by Private Equity Firms
JMP Securities Reiterates Market Outperform on CureVac, Maintains $16 Price Target